Superworth

Standard Biotools EPS LAB

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
$0.22
Latest quarter, Q2 FY26
−$0.07
Fiscal year 2025
−$0.20

Standard Biotools' earnings per share was $0.22 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.07.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.20n/a
FY2024−$0.55n/a
FY2023−$0.95n/a
FY2022−$2.44n/a
FY2021−$0.78n/a
FY2020−$0.73n/a
FY2019−$1.01n/a
FY2018−$1.50n/a
FY2017−$1.90n/a
FY2016−$2.62n/a
FY2015−$1.86n/a
FY2014−$1.90n/a
FY2013−$0.65n/a
FY2012−$0.87n/a
FY2011−$2.35n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.07n/a$0.22
Q1 FY26$0.33n/a$0.20
Q4 FY25$0.05n/a−$0.20
Q3 FY25−$0.09n/a−$0.34
Q2 FY25−$0.09n/a−$0.32
Q1 FY25−$0.07n/a−$0.35
Q4 FY24−$0.09n/a−$0.55
Q3 FY24−$0.07n/a−$0.71
Q2 FY24−$0.12n/a−$0.91
Q1 FY24−$0.27n/a−$1.01
Q4 FY23−$0.25n/a−$0.95
Q3 FY23−$0.27n/a−$0.96

Against its peers

Companies in Drug Manufacturers - General nearest Standard Biotools' size, closest first, today.

CompanyEPS, 12 monthsGrowth
LABStandard Biotools$0.22
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
LFVNLifevantage$0.40−46% a year
ABUSArbutus Biopharma$0.78
SPROSpero Therapeutics$0.11
Peer median$0.78

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Standard Biotools

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.